Perinatal manifestations of congenital disorders of glycosylation—A clue to early diagnosis [PDF]
N-glycosylation defects—isolated or mixed with other glycosylation defects—are the most frequent congenital disorders of glycosylation and present mostly in childhood, with a specific combination of non-specific phenotypic features.
Milena Greczan +5 more
doaj +4 more sources
Treatment Options in Congenital Disorders of Glycosylation [PDF]
Despite advances in the identification and diagnosis of congenital disorders of glycosylation (CDG), treatment options remain limited and are often constrained to symptomatic management of disease manifestations.
Julien H. Park, Thorsten Marquardt
doaj +5 more sources
Congenital Disorders of Glycosylation: What Clinicians Need to Know? [PDF]
Congenital disorders of glycosylation (CDG) are a group of clinically heterogeneous disorders characterized by defects in the synthesis of glycans and their attachment to proteins and lipids.
Patryk Lipiński, Anna Tylki-Szymańska
doaj +4 more sources
Endocrine Implications of Congenital Disorders of Glycosylation [PDF]
Glycosylation, attachment of monosaccharides or glycans to specific residues of proteins and lipids, is the most common post-translational modification. Defects among glycoprotein synthesis or modification pathways result in a genetically and clinically ...
Yağmur Ünsal, Zeynep Alev Özön
doaj +2 more sources
Zebrafish models for congenital disorders of glycosylation (CDG): a systematic review [PDF]
Glycosylation is a post-translational modification of proteins that involves the addition of glycan groups and is essential for their proper functionality. This highly complex process affects 70% of all human proteins.
N. Gandoy-Fieiras +2 more
doaj +2 more sources
Congenital Disorders of Glycosylation from a Neurological Perspective
Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post-translational transformation of most human proteins.
Justyna Paprocka +3 more
doaj +3 more sources
Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation [PDF]
Background: Congenital disorders of glycosylation (CDG) and NGLY1-CDDG (NGLY1-congenital disorder of deglycosylation) usually represent multisystem (especially neurovisceral) diseases with liver involvement reported in some of them.
Patryk Lipiński +3 more
doaj +2 more sources
Novel mutation of COG5 in a Taiwanese girl with congenital disorders of glycosylation manifesting as developmental delay [PDF]
We are documenting the case of An 11-year-old girl who has been followed up at our out-patient clinic since birth with clinical presentations including intrauterine growth restriction, recurrent periodic fever in infancy, hypotonia, global developmental ...
Yu-Chi Wang +4 more
doaj +2 more sources
Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan [PDF]
Congenital disorders of glycosylation (CDG) are a heterogeneous group of diseases caused by defects in various steps of the glycosylation pathway. There are over 200 known human glycosylation‐related disorders. Many of these defects lead to multisystemic
Nobuhiko Okamoto +2 more
doaj +2 more sources
Congenital disorders of glycosylation (CDG) are a widely acknowledged group of metabolic diseases. PMM2-CDG is the most frequently diagnosed CDG with a prevalence as high as one in 20,000.
Sander Pajusalu +10 more
doaj +3 more sources

